AlphaStocks
6.0
Consider Buy

METLIFE INC (MET)

Financials / Life & Health Insurance

S&P 500

$96.31

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#26out of 50 in Financials

Is METLIFE INC a Good Investment in 2026?

METLIFE INC (MET) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates METLIFE INC as Attractive (6/9). The Graham model is the least favorable, rating it Neutral. METLIFE INC currently trades above its estimated fair value of $59, suggesting limited upside at current prices. METLIFE INC ranks #26 out of 50 stocks in the Financials sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E19.2ROE11.8Market Cap63BDiv Yield2.4

Estimated Fair Value

$59.0363% above

Trading above estimated fair value. Eps growth of -19% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

67% above fair value

Lynch

Limited Data

High PEG — growth premium

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is METLIFE INC (MET) a good investment?
Based on AlphaStocks' composite analysis, METLIFE INC (MET) scores 6.0 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading above estimated fair value. Eps growth of -19% may not justify the premium.
What is METLIFE INC's Piotroski F-Score?
METLIFE INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MET overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $59, MET appears overvalued. The stock currently trades 63% above its estimated fair value. Trading above estimated fair value. Eps growth of -19% may not justify the premium.
How does MET compare to other Financials stocks?
METLIFE INC ranks #26 out of 50 stocks in the Financials sector, placing it in the top 52% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about MET?
AlphaStocks evaluates MET using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral. These models are combined into a single composite score of 6.0/10.

Similar Stocks

EGTRVRDN

Compare MET with

MET vs EGMET vs TRVMET vs RDN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer